SUN-LB135 Estrogen Receptor Beta Inhibits NFkB Signaling to Inhibit Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) affects approximately 15-20% of BC patients, yet accounts for a disproportionately higher rate of BC morbidity and mortality, in part due to lack of targeted therapies. We have shown that estrogen receptor beta (ERβ) is expressed in approximately 20% of TN breast...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Aspros, Kirsten, Subramaniam, Malayannan, Ye, Zhenqing, Sun, Zhifu, Ingle, James, Goetz, Matthew, Hawse, John
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Steroid Hormones and Receptors
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208680/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2252
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы